Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIBTEG: Single-dose fibrinogen vs placebo in ascending aorta surgery
2013-002820-18Phase 4Active
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative hemorrhage, coagulopathy, thoracic aortic aneurysm (TAA) and 1 more comparing Fibrinogen concentrate with Placebo (2 arms). Primary endpoint: Allogeneic blood transfusions within 24 hours. Started Apr 2014; status: active.
02
Drugs
Fibrinogen human
03
Conditions
postoperative hemorrhagecoagulopathythoracic aortic aneurysm (TAA)thoracic aortic dissection (TAD)
Beyond the preview
Go deeper on 2013-002820-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002820-18.